Journal of the American Chemical Society
Communication
examples of enantioselective protonation not involving nitroalkenes,
see: (b) Wang, Y.; Liu, X.; Deng, L. J. Am. Chem. Soc. 2006, 128, 3928.
(c) Kieffer, M. E.; Repka, L. M.; Reisman, S. E. J. Am. Chem. Soc. 2012,
134, 5131. (d) Sadow, A. D.; Haller, I.; Fadini, L.; Togni, A. J. Am.
Chem. Soc. 2004, 126, 14704.
ASSOCIATED CONTENT
* Supporting Information
Complete experimental procedures, product characterization,
HPLC traces, and a CIF file. This material is available free of
■
S
(9) (a) Gruel, J. N.; Gaertzen, O.; Helmke, H.; Hilebrand, S.; Ilg, K.;
Mattes, A.; Wasnaire, P.; Nising, C. F.; Wachendorff-Neumann, U.;
Voerste, A.; Dahmen, P.; Meisssner, R.; Braun, C. A.; Kaussmann, M.;
Hadano, H. Preparation of Analinopyrimidines as Agrochemical
Fungicides. Patent WO 2010025831 (A1). (b) Stierle, A. A.; Stierle,
D. B.; Patachini, B. J. Nat. Prod. 2008, 71, 856. (c) Aicher, T. D.;
Chicarelli, M. J.; Hinklin, R. J.; Tian, H.; Wallace, O. B.; Chen, Z.;
Marby, T. E.; McCowan, J. R.; Snyder, N. J.; Winneroski, L. L.;
Leonard, L.; Allen, J. G. Preparation of Cycloalkyl Lactam Derivatives,
Particularly N-Substituted Pyrrolidin-2-ones, as Inhibitors of 11β-
Hydroxysteroid Dehydrogenase 1. Patent WO 200649952 A1.
(d) Askew, B. C.; Smith, G. R. Synthesis and Use of Substituted
Pyrrolidin-1-yl-Hexanoic Acid Derivatives as avβ3 and avβ5 Integrin
Receptors. Patent WO2001024797 A1.
AUTHOR INFORMATION
Corresponding Author
■
Author Contributions
†K.L.K. and J.D.W. contributed equally.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by NSF (CHE-1049571). We thank
A. Rheingold and the UCSD X-ray crystallography facility for
solving the crystal structure of 7a and Dr. C. Senanayake at
Boehringer Ingelheim for supplying trisylsulfinamide.
(10) For catalytic enantioselective methods that provide access to the
4-substituted pyrrolidinones, see: (a) Okino, T.; Hoashi, Y.;
Furukawa, T.; Xu, X.; Takemoto, Y. J. Am. Chem. Soc. 2005, 127,
119. For a general method to access 4,5-disubstituted pyrrolidinones,
see: (b) Reference 1. For access to 3,4,5-trisubstituted pyrrolidinones,
REFERENCES
■
see: (c) Duschmale,
For a nice review of diastereoselective methods, see: (d) Ordon
Cativiela, C. Tetrahedron: Asymmetry 2007, 18, 3.
́
J.; Wennemers, H. Chem.Eur. J. 2012, 18, 1111.
(1) Kimmel, K. L.; Weaver, J. D.; Ellman, J. A. Chem. Sci. 2012, 3,
121.
́
ez, M.;
̃
(2) For enantioselective catalytic additions of Meldrum’s acid to β-
substituted nitroalkenes proceeding with modest selectivities, see:
(a) Okino, T.; Hoashi, Y.; Takemoto, Y. J. Am. Chem. Soc. 2003, 125,
12672. (b) Bassas, O.; Huuskenon, J.; Rissanen, K.; Koskinen, A. M. P.
Eur. J. Org. Chem. 2009, 1340. (c) Kleczkowska, E.; Sas, W. Pol. J.
Chem. 2007, 81, 1457.
(11) Use of unsubstituted Meldrum’s acid led to overalkylation.
(12) Catalyst 3d provided 9a with 57% ee at 23 °C and 77% ee at
−15 °C, whereas 3a provided 9a with 50% ee at 23 °C and 62% ee at
−15 °C. The greater temperature effect may result from the increased
amount of rotational freedom in 3d, which upon cooling increasingly
reacts through a more selective conformer.
(3) For leading references on the organocatalytic addition of the
related malonates to β-substituted and cyclic α,β-disubstituted
nitroalkenes, see: (a) Reference 2a. (b) Ye, J.; Dixon, D. J.; Hynes,
P. S. Chem. Commun. 2005, 4481. (c) Li, H.; Wang, L. T.; Deng, L. J.
Am. Chem. Soc. 2004, 126, 9906. (d) Xu, F.; Corley, E.; Zacuto, M.;
Conlon, D. A.; Pipik, B.; Humphrey, G.; Murry, J.; Tschaen, D. J. Org.
Chem. 2010, 75, 1343. (e) McCooey, S. H.; Connon, S. J. Angew.
Chem., Int. Ed. 2005, 44, 6367. (f) Zhang, L.; Lee, M.-M.; Lee, S.-M.;
Lee, J.; Cheng, M.; Jeong, B.-S.; Park, H.-G.; Jew, S.-S. Adv. Synth.
Catal. 2009, 351, 3063. (g) Chen, W.-Y.; Li, P.; Xie, J.-W.; Li, X.-S.
Catal. Commun. 2011, 12, 502.
(13) For a nice example of the design of an innovative four-carbon
chiral diamine linker, see: Palacio, C.; Connon, S. J. Chem. Commun.
2012, 48, 2849.
(14) Morpholine is ∼2 pKa units less basic than piperidine.4
(15) Catalyst 3k was made via 1,1’-carbonyldiimidazole coupling of
commercially available trisylsulfinamide and 2-methyl-2-morpholino-
propan-1-amine in ∼80% yield on a 1 mmol scale. The synthesis of the
piperazine catalysts (3m−p) was lengthier. See the SI for full details.
(16) The racemic β-hydroxynitroalkane generated by hydration of
the nitroalkene starting material reduced the enantioselectivity of the
reaction. Molecular sieves prevented formation of this product and
consequently resulted in improved reproducibility.
(4) Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456.
(5) For reviews of H-bonding catalysis, see: (a) Taylor, M. S.;
Jacobsen, E. N. Angew. Chem., Int. Ed. 2006, 45, 1520. (b) Takemoto,
Y. Org. Biomol. Chem. 2005, 3, 4299. (c) Doyle, A. G.; Jacobsen, E. N.
Chem. Rev. 2007, 107, 5713. (d) Akiyama, T. Chem. Rev. 2007, 107,
5744. (e) Yu, X.; Wang, W. Chem.Asian J. 2008, 3, 516. (f) Terada,
M. Synthesis 2010, 1929. (g) Rueping, M.; Koenigs, R. M.; Atodiresei,
I. Chem.Eur. J. 2010, 16, 9350.
(17) For indium-mediated nitro reduction, see: Singh, V.; Kanojiya,
S.; Batra, S. Tetrahedron 2006, 62, 10100.
(18) Reduction occurred with preservation of the α-nitro stereo-
center under the indium/HCl conditions. Enantiomeric purities were
determined by chiral HPLC analysis.
(19) (a) Diastereoselective decarboxylative protonation of 3-
substituted pyrrolidinones has been reported only for an N-H
pyrrolidinone (with ∼3:1 dr) and an N-pivaloyl pyrrolidinone (with
55:45 dr). See: Hook, D.; Thomas, R.; Bernhard, R.; Wietfeld, B.;
Sedelmeier, G.; Napp, M.; Baenziger, M.; Hawker, S.; Ciszewski, L.;
Waykole, L. M. New Process. WO2008083967 (A2). (b) In analogy
with Meyers’ alkylations of enolates of simple N-methyl-5-methyl-
pyrrolidinone, it was expected that the decarboxylative protonation
should also take place from the face opposite the 5-substituent and
that the magnitude of the diastereoselectivity would be greater for N-H
than N-carbamoyl pyrrolidinones. For an excellent explanation of this
phenomenon, see: Meyers, A. I.; Seefeld, M. A.; Lefker, B. A.; Blake, J.
F. J. Am. Chem. Soc. 1997, 119, 4565.
(6) For examples of organocatalysts containing sulfinamide, see: (a)
Reference 1. (b) Robak, M. T.; Trincado, M.; Ellman, J. A. J. Am.
Chem. Soc. 2007, 129, 15110. (c) Kimmel, K. L.; Robak, M. T.; Ellman,
J. A. J. Am. Chem. Soc. 2009, 131, 8754. (d) Kimmel, K. L.; Robak, M.
T.; Thomas, S.; Lee, M.; Ellman, J. A. Tetrahedron 2012, 68, 2704.
(e) Robak, M. T.; Herbage, M. A.; Ellman, J. A. Tetrahedron 2011, 67,
4412. (f) Xu, H.; Zuend, S. J.; Woll, M. G.; Tao, Y.; Jacobsen, E. N.
Science 2010, 327, 986. (g) Pei, D.; Wang, Z.; Wei, S.; Zhang, Y.; Sun,
J. Org. Lett. 2006, 8, 5913.
(7) For an example of a chiral auxiliary approach to asymmetric [4 +
2] cycloaddition involving a terminally unsubstituted nitroalkene, see:
(a) Barluenga, J.; Aznar, F.; Ribas, C.; Valdes, C. J. Org. Chem. 1997,
́
62, 6746. For an example of nucleophilic addition to a terminally
unsubstituted nitroalkene to form a cyclic product with diastereose-
lective protonation via thermodynamic control, see entry 13 of Table 2
in: (b) Wang, Y.; Zhu, S.; Ma, D. Org. Lett. 2011, 13, 1602.
(20) The relative configuration of decarboxylated lactam 9a was
determined to be cis by correlation with literature 1H NMR data. See:
Crich, D.; Ranganathan, K. J. Am. Chem. Soc. 2005, 127, 9924.
(8) For a review of enantioselective protonation, see: (a) Mohr, J.
T.; Hong, A. Y.; Stoltz, B. M. Nat. Chem. 2009, 1, 359. For selected
D
dx.doi.org/10.1021/ja3026196 | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX